Revision 25 for 'Octreotide scintigraphy'

All Revisions - View changeset

Octreotide scintigraphy

Octreotide scintigraphy uses 111In-labeled octreotide which is a somatostatin analog; it is also known as an OctreoscanTM, a brand name for 111In-labeled pentetreotide; pentetreotide is a DTPA-conjugated form of octreotide, originally manufactured by Mallinckrodt Nuclear Medicine LLC, which now forms part of Curium). It is particularly useful for assessment of neuroendocrine tumors.

Examples include:

Certain non-neuroendocrine tumors can also show uptake in an octreoscan. Examples include:

Also, certain autoimmune or granulomatous diseases may occasionally show octreotide uptake.

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.